Among the tumor-infiltrating cells analyzed, CD4+ T cells were statistically increased in WEHI-164 and K7M2 tumor-bearing mice which had been subjected to all protocol treatments, in comparison with untreated tumor–bearing mice (Fig. 3A and D). The gene discussed is CD4; the disease is neoplasm.